The introduction of nicotinamide to be a nicotine replacement in e-cigarette and smokeless products and solutions signifies a substantial regulatory challenge with the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is thought to act as a sedative at significant dosages6. Th